| Merlin D Larson, MD | |
|
1600 Divisadero St, San Francisco, CA 94143-0001 | |
| (415) 885-7412 | |
| (415) 885-7284 |
| Full Name | Merlin D Larson |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 1600 Divisadero St, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003872805 | NPI | - | NPPES |
| 00C307070 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | C30707 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Merlin D Larson, MD 1635 Divisadero St, Ste. 625, Box 1821, San Francisco, CA 94143-0001 Ph: () - | Merlin D Larson, MD 1600 Divisadero St, San Francisco, CA 94143-0001 Ph: (415) 885-7412 |
News Archive
Research has identified a number of variables associated with nonalcoholic fatty liver disease in obese children.
Venous thromboembolism (VTE) is the third most common type of cardiovascular disease after coronary heart disease and stroke. Researchers at the Centre for Primary Health Care Research in Malmö have mapped the significance of hereditary factors for venous thromboembolism in the entire Swedish population by studying the risk of VTE in children of parents with VTE compared with the children of parents who have not had VTE.
Porvair Sciences announces the availability of a new guide that improves your background knowledge and makes selection of the optimum deep-well microplate for your application both quick and easy.
Springer is launching a new journal Autoimmunity Highlights, an independent, international, peer-reviewed journal that publishes papers related to the diverse aspects of autoimmunity, and seeks to be a bridge between the clinic, the laboratory and the specialists who are involved in the complex world of autoimmunity diagnosis.
AstraZeneca has announced that it has completed patient enrollment in two pivotal Phase III studies for vandetanib, the company's investigational, once-daily oral anti-cancer drug, for the second-line treatment of non-small cell lung cancer (NSCLC).
› Verified 1 days ago
Dr. Taylor Bergh Bucyk, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1001 Potrero Ave # 3c38, San Francisco, CA 94110 Phone: 628-206-8000 | |
Dr. Celine Marie Madeleine Gonzalez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1305 Waller St, San Francisco, CA 94117 Phone: 415-640-9777 | |
David Howard Irwin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3700 California St, San Francisco, CA 94118 Phone: 415-719-0000 | |
Steven Gary Vitcov, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3700 California St, San Francisco, CA 94118 Phone: 415-719-0000 | |
Chris Abrecht, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2351 Clay St, Suite 380, San Francisco, CA 94115 Phone: 415-600-3954 | |
Sam Sheng Shay, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3700 California St, San Francisco, CA 94118 Phone: 415-719-0000 |